Global Biological Hemostatic Material Market Growth 2026-2032

September 2026 | 143 pages | ID: G2759928CC52EN
LP Information

Abstracts

The global Biological Hemostatic Material market size is predicted to grow from US$ 612 million in 2025 to US$ 926 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LP Information, Inc. (LPI) ' newest research report, the “Biological Hemostatic Material Industry Forecast” looks at past sales and reviews total world Biological Hemostatic Material sales in 2025, providing a comprehensive analysis by region and market sector of projected Biological Hemostatic Material sales for 2026 through 2032. With Biological Hemostatic Material sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Hemostatic Material industry.

This Insight Report provides a comprehensive analysis of the global Biological Hemostatic Material landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Hemostatic Material portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Hemostatic Material market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Hemostatic Material and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Hemostatic Material.

This report presents a comprehensive overview, market shares, and growth opportunities of Biological Hemostatic Material market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Collagen
• Gelatin
• Polysaccharides
• Other

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Johnson & Johnson
• BD
• Baxter
• B.Braun
• Cura Medical
• GELITA MEDICAL
• Curasan AG
• Meril Life Sciences
• Zhonghui Shengxi
• Beijing Datsing Bio-tech
• Guizhou Jin Jiu Biotech
• Beijing Taikesiman
• Foryou Medical
• Saikesaisi Holdings Group
• Biotemed
• Hangzhou Singclean Medical Products

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Biological Hemostatic Material market?
• What factors are driving Biological Hemostatic Material market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Biological Hemostatic Material market opportunities vary by end market size?
• How does Biological Hemostatic Material break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biological Hemostatic Material Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Biological Hemostatic Material by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Biological Hemostatic Material by Country/Region, 2021, 2025 & 2032
2.2 Biological Hemostatic Material Segment by Type
  2.2.1 Collagen
  2.2.2 Gelatin
  2.2.3 Polysaccharides
  2.2.4 Other
  2.2.5 Biological Hemostatic Material Sales by Type
    2.2.5.1 Global Biological Hemostatic Material Sales Market Share by Type (2021-2026)
    2.2.5.2 Global Biological Hemostatic Material Revenue and Market Share by Type (2021-2026)
    2.2.5.3 Global Biological Hemostatic Material Sale Price by Type (2021-2026)
2.3 Biological Hemostatic Material Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Biological Hemostatic Material Sales by Application
    2.3.4.1 Global Biological Hemostatic Material Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Biological Hemostatic Material Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Biological Hemostatic Material Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Biological Hemostatic Material Breakdown Data by Company
  3.1.1 Global Biological Hemostatic Material Annual Sales by Company (2021-2026)
  3.1.2 Global Biological Hemostatic Material Sales Market Share by Company (2021-2026)
3.2 Global Biological Hemostatic Material Annual Revenue by Company (2021-2026)
  3.2.1 Global Biological Hemostatic Material Revenue by Company (2021-2026)
  3.2.2 Global Biological Hemostatic Material Revenue Market Share by Company (2021-2026)
3.3 Global Biological Hemostatic Material Sale Price by Company
3.4 Key Manufacturers Biological Hemostatic Material Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Biological Hemostatic Material Product Location Distribution
  3.4.2 Players Biological Hemostatic Material Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BIOLOGICAL HEMOSTATIC MATERIAL BY GEOGRAPHIC REGION

4.1 World Historic Biological Hemostatic Material Market Size by Geographic Region (2021-2026)
  4.1.1 Global Biological Hemostatic Material Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Biological Hemostatic Material Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Biological Hemostatic Material Market Size by Country/Region (2021-2026)
  4.2.1 Global Biological Hemostatic Material Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Biological Hemostatic Material Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biological Hemostatic Material Sales Growth
4.4 APAC Biological Hemostatic Material Sales Growth
4.5 Europe Biological Hemostatic Material Sales Growth
4.6 Middle East & Africa Biological Hemostatic Material Sales Growth

5 AMERICAS

5.1 Americas Biological Hemostatic Material Sales by Country
  5.1.1 Americas Biological Hemostatic Material Sales by Country (2021-2026)
  5.1.2 Americas Biological Hemostatic Material Revenue by Country (2021-2026)
5.2 Americas Biological Hemostatic Material Sales by Type (2021-2026)
5.3 Americas Biological Hemostatic Material Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biological Hemostatic Material Sales by Region
  6.1.1 APAC Biological Hemostatic Material Sales by Region (2021-2026)
  6.1.2 APAC Biological Hemostatic Material Revenue by Region (2021-2026)
6.2 APAC Biological Hemostatic Material Sales by Type (2021-2026)
6.3 APAC Biological Hemostatic Material Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Biological Hemostatic Material by Country
  7.1.1 Europe Biological Hemostatic Material Sales by Country (2021-2026)
  7.1.2 Europe Biological Hemostatic Material Revenue by Country (2021-2026)
7.2 Europe Biological Hemostatic Material Sales by Type (2021-2026)
7.3 Europe Biological Hemostatic Material Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biological Hemostatic Material by Country
  8.1.1 Middle East & Africa Biological Hemostatic Material Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Biological Hemostatic Material Revenue by Country (2021-2026)
8.2 Middle East & Africa Biological Hemostatic Material Sales by Type (2021-2026)
8.3 Middle East & Africa Biological Hemostatic Material Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biological Hemostatic Material
10.3 Manufacturing Process Analysis of Biological Hemostatic Material
10.4 Industry Chain Structure of Biological Hemostatic Material

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Biological Hemostatic Material Distributors
11.3 Biological Hemostatic Material Customer

12 WORLD FORECAST REVIEW FOR BIOLOGICAL HEMOSTATIC MATERIAL BY GEOGRAPHIC REGION

12.1 Global Biological Hemostatic Material Market Size Forecast by Region
  12.1.1 Global Biological Hemostatic Material Forecast by Region (2027-2032)
  12.1.2 Global Biological Hemostatic Material Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Biological Hemostatic Material Forecast by Type (2027-2032)
12.7 Global Biological Hemostatic Material Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Biological Hemostatic Material Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments
13.2 BD
  13.2.1 BD Company Information
  13.2.2 BD Biological Hemostatic Material Product Portfolios and Specifications
  13.2.3 BD Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 BD Main Business Overview
  13.2.5 BD Latest Developments
13.3 Baxter
  13.3.1 Baxter Company Information
  13.3.2 Baxter Biological Hemostatic Material Product Portfolios and Specifications
  13.3.3 Baxter Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Baxter Main Business Overview
  13.3.5 Baxter Latest Developments
13.4 B.Braun
  13.4.1 B.Braun Company Information
  13.4.2 B.Braun Biological Hemostatic Material Product Portfolios and Specifications
  13.4.3 B.Braun Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 B.Braun Main Business Overview
  13.4.5 B.Braun Latest Developments
13.5 Cura Medical
  13.5.1 Cura Medical Company Information
  13.5.2 Cura Medical Biological Hemostatic Material Product Portfolios and Specifications
  13.5.3 Cura Medical Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Cura Medical Main Business Overview
  13.5.5 Cura Medical Latest Developments
13.6 GELITA MEDICAL
  13.6.1 GELITA MEDICAL Company Information
  13.6.2 GELITA MEDICAL Biological Hemostatic Material Product Portfolios and Specifications
  13.6.3 GELITA MEDICAL Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 GELITA MEDICAL Main Business Overview
  13.6.5 GELITA MEDICAL Latest Developments
13.7 Curasan AG
  13.7.1 Curasan AG Company Information
  13.7.2 Curasan AG Biological Hemostatic Material Product Portfolios and Specifications
  13.7.3 Curasan AG Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Curasan AG Main Business Overview
  13.7.5 Curasan AG Latest Developments
13.8 Meril Life Sciences
  13.8.1 Meril Life Sciences Company Information
  13.8.2 Meril Life Sciences Biological Hemostatic Material Product Portfolios and Specifications
  13.8.3 Meril Life Sciences Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Meril Life Sciences Main Business Overview
  13.8.5 Meril Life Sciences Latest Developments
13.9 Zhonghui Shengxi
  13.9.1 Zhonghui Shengxi Company Information
  13.9.2 Zhonghui Shengxi Biological Hemostatic Material Product Portfolios and Specifications
  13.9.3 Zhonghui Shengxi Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Zhonghui Shengxi Main Business Overview
  13.9.5 Zhonghui Shengxi Latest Developments
13.10 Beijing Datsing Bio-tech
  13.10.1 Beijing Datsing Bio-tech Company Information
  13.10.2 Beijing Datsing Bio-tech Biological Hemostatic Material Product Portfolios and Specifications
  13.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Beijing Datsing Bio-tech Main Business Overview
  13.10.5 Beijing Datsing Bio-tech Latest Developments
13.11 Guizhou Jin Jiu Biotech
  13.11.1 Guizhou Jin Jiu Biotech Company Information
  13.11.2 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Portfolios and Specifications
  13.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Guizhou Jin Jiu Biotech Main Business Overview
  13.11.5 Guizhou Jin Jiu Biotech Latest Developments
13.12 Beijing Taikesiman
  13.12.1 Beijing Taikesiman Company Information
  13.12.2 Beijing Taikesiman Biological Hemostatic Material Product Portfolios and Specifications
  13.12.3 Beijing Taikesiman Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Beijing Taikesiman Main Business Overview
  13.12.5 Beijing Taikesiman Latest Developments
13.13 Foryou Medical
  13.13.1 Foryou Medical Company Information
  13.13.2 Foryou Medical Biological Hemostatic Material Product Portfolios and Specifications
  13.13.3 Foryou Medical Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Foryou Medical Main Business Overview
  13.13.5 Foryou Medical Latest Developments
13.14 Saikesaisi Holdings Group
  13.14.1 Saikesaisi Holdings Group Company Information
  13.14.2 Saikesaisi Holdings Group Biological Hemostatic Material Product Portfolios and Specifications
  13.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Saikesaisi Holdings Group Main Business Overview
  13.14.5 Saikesaisi Holdings Group Latest Developments
13.15 Biotemed
  13.15.1 Biotemed Company Information
  13.15.2 Biotemed Biological Hemostatic Material Product Portfolios and Specifications
  13.15.3 Biotemed Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Biotemed Main Business Overview
  13.15.5 Biotemed Latest Developments
13.16 Hangzhou Singclean Medical Products
  13.16.1 Hangzhou Singclean Medical Products Company Information
  13.16.2 Hangzhou Singclean Medical Products Biological Hemostatic Material Product Portfolios and Specifications
  13.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Hangzhou Singclean Medical Products Main Business Overview
  13.16.5 Hangzhou Singclean Medical Products Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biological Hemostatic Material Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Biological Hemostatic Material Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Collagen
Table 4. Major Players of Gelatin
Table 5. Major Players of Polysaccharides
Table 6. Major Players of Other
Table 7. Global Biological Hemostatic Material Sales by Type (2021-2026) & (K Units)
Table 8. Global Biological Hemostatic Material Sales Market Share by Type (2021-2026)
Table 9. Global Biological Hemostatic Material Revenue by Type (2021-2026) & ($ million)
Table 10. Global Biological Hemostatic Material Revenue Market Share by Type (2021-2026)
Table 11. Global Biological Hemostatic Material Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Biological Hemostatic Material Sale by Application (2021-2026) & (K Units)
Table 13. Global Biological Hemostatic Material Sale Market Share by Application (2021-2026)
Table 14. Global Biological Hemostatic Material Revenue by Application (2021-2026) & ($ million)
Table 15. Global Biological Hemostatic Material Revenue Market Share by Application (2021-2026)
Table 16. Global Biological Hemostatic Material Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Biological Hemostatic Material Sales by Company (2021-2026) & (K Units)
Table 18. Global Biological Hemostatic Material Sales Market Share by Company (2021-2026)
Table 19. Global Biological Hemostatic Material Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Biological Hemostatic Material Revenue Market Share by Company (2021-2026)
Table 21. Global Biological Hemostatic Material Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Biological Hemostatic Material Producing Area Distribution and Sales Area
Table 23. Players Biological Hemostatic Material Products Offered
Table 24. Biological Hemostatic Material Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Biological Hemostatic Material Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Biological Hemostatic Material Sales Market Share Geographic Region (2021-2026)
Table 29. Global Biological Hemostatic Material Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Biological Hemostatic Material Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Biological Hemostatic Material Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Biological Hemostatic Material Sales Market Share by Country/Region (2021-2026)
Table 33. Global Biological Hemostatic Material Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Biological Hemostatic Material Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Biological Hemostatic Material Sales by Country (2021-2026) & (K Units)
Table 36. Americas Biological Hemostatic Material Sales Market Share by Country (2021-2026)
Table 37. Americas Biological Hemostatic Material Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Biological Hemostatic Material Sales by Type (2021-2026) & (K Units)
Table 39. Americas Biological Hemostatic Material Sales by Application (2021-2026) & (K Units)
Table 40. APAC Biological Hemostatic Material Sales by Region (2021-2026) & (K Units)
Table 41. APAC Biological Hemostatic Material Sales Market Share by Region (2021-2026)
Table 42. APAC Biological Hemostatic Material Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Biological Hemostatic Material Sales by Type (2021-2026) & (K Units)
Table 44. APAC Biological Hemostatic Material Sales by Application (2021-2026) & (K Units)
Table 45. Europe Biological Hemostatic Material Sales by Country (2021-2026) & (K Units)
Table 46. Europe Biological Hemostatic Material Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Biological Hemostatic Material Sales by Type (2021-2026) & (K Units)
Table 48. Europe Biological Hemostatic Material Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Biological Hemostatic Material Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Biological Hemostatic Material Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Biological Hemostatic Material Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Biological Hemostatic Material Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Biological Hemostatic Material
Table 54. Key Market Challenges & Risks of Biological Hemostatic Material
Table 55. Key Industry Trends of Biological Hemostatic Material
Table 56. Biological Hemostatic Material Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Biological Hemostatic Material Distributors List
Table 59. Biological Hemostatic Material Customer List
Table 60. Global Biological Hemostatic Material Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Biological Hemostatic Material Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Biological Hemostatic Material Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Biological Hemostatic Material Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Biological Hemostatic Material Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Biological Hemostatic Material Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Biological Hemostatic Material Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Biological Hemostatic Material Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Biological Hemostatic Material Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Biological Hemostatic Material Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Biological Hemostatic Material Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Biological Hemostatic Material Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Biological Hemostatic Material Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Biological Hemostatic Material Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Johnson & Johnson Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 75. Johnson & Johnson Biological Hemostatic Material Product Portfolios and Specifications
Table 76. Johnson & Johnson Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Latest Developments
Table 79. BD Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 80. BD Biological Hemostatic Material Product Portfolios and Specifications
Table 81. BD Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. BD Main Business
Table 83. BD Latest Developments
Table 84. Baxter Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 85. Baxter Biological Hemostatic Material Product Portfolios and Specifications
Table 86. Baxter Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Baxter Main Business
Table 88. Baxter Latest Developments
Table 89. B.Braun Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 90. B.Braun Biological Hemostatic Material Product Portfolios and Specifications
Table 91. B.Braun Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. B.Braun Main Business
Table 93. B.Braun Latest Developments
Table 94. Cura Medical Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 95. Cura Medical Biological Hemostatic Material Product Portfolios and Specifications
Table 96. Cura Medical Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Cura Medical Main Business
Table 98. Cura Medical Latest Developments
Table 99. GELITA MEDICAL Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 100. GELITA MEDICAL Biological Hemostatic Material Product Portfolios and Specifications
Table 101. GELITA MEDICAL Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. GELITA MEDICAL Main Business
Table 103. GELITA MEDICAL Latest Developments
Table 104. Curasan AG Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 105. Curasan AG Biological Hemostatic Material Product Portfolios and Specifications
Table 106. Curasan AG Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Curasan AG Main Business
Table 108. Curasan AG Latest Developments
Table 109. Meril Life Sciences Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 110. Meril Life Sciences Biological Hemostatic Material Product Portfolios and Specifications
Table 111. Meril Life Sciences Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Meril Life Sciences Main Business
Table 113. Meril Life Sciences Latest Developments
Table 114. Zhonghui Shengxi Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 115. Zhonghui Shengxi Biological Hemostatic Material Product Portfolios and Specifications
Table 116. Zhonghui Shengxi Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Zhonghui Shengxi Main Business
Table 118. Zhonghui Shengxi Latest Developments
Table 119. Beijing Datsing Bio-tech Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 120. Beijing Datsing Bio-tech Biological Hemostatic Material Product Portfolios and Specifications
Table 121. Beijing Datsing Bio-tech Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Beijing Datsing Bio-tech Main Business
Table 123. Beijing Datsing Bio-tech Latest Developments
Table 124. Guizhou Jin Jiu Biotech Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 125. Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Portfolios and Specifications
Table 126. Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Guizhou Jin Jiu Biotech Main Business
Table 128. Guizhou Jin Jiu Biotech Latest Developments
Table 129. Beijing Taikesiman Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 130. Beijing Taikesiman Biological Hemostatic Material Product Portfolios and Specifications
Table 131. Beijing Taikesiman Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Beijing Taikesiman Main Business
Table 133. Beijing Taikesiman Latest Developments
Table 134. Foryou Medical Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 135. Foryou Medical Biological Hemostatic Material Product Portfolios and Specifications
Table 136. Foryou Medical Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Foryou Medical Main Business
Table 138. Foryou Medical Latest Developments
Table 139. Saikesaisi Holdings Group Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 140. Saikesaisi Holdings Group Biological Hemostatic Material Product Portfolios and Specifications
Table 141. Saikesaisi Holdings Group Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Saikesaisi Holdings Group Main Business
Table 143. Saikesaisi Holdings Group Latest Developments
Table 144. Biotemed Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 145. Biotemed Biological Hemostatic Material Product Portfolios and Specifications
Table 146. Biotemed Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Biotemed Main Business
Table 148. Biotemed Latest Developments
Table 149. Hangzhou Singclean Medical Products Basic Information, Biological Hemostatic Material Manufacturing Base, Sales Area and Its Competitors
Table 150. Hangzhou Singclean Medical Products Biological Hemostatic Material Product Portfolios and Specifications
Table 151. Hangzhou Singclean Medical Products Biological Hemostatic Material Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Hangzhou Singclean Medical Products Main Business
Table 153. Hangzhou Singclean Medical Products Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Biological Hemostatic Material
Figure 2. Biological Hemostatic Material Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biological Hemostatic Material Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Biological Hemostatic Material Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Biological Hemostatic Material Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Biological Hemostatic Material Sales Market Share by Country/Region (2025)
Figure 10. Biological Hemostatic Material Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Collagen
Figure 12. Product Picture of Gelatin
Figure 13. Product Picture of Polysaccharides
Figure 14. Product Picture of Other
Figure 15. Global Biological Hemostatic Material Sales Market Share by Type in 2026
Figure 16. Global Biological Hemostatic Material Revenue Market Share by Type (2021-2026)
Figure 17. Biological Hemostatic Material Consumed in Hospital
Figure 18. Global Biological Hemostatic Material Market: Hospital (2021-2026) & (K Units)
Figure 19. Biological Hemostatic Material Consumed in Clinic
Figure 20. Global Biological Hemostatic Material Market: Clinic (2021-2026) & (K Units)
Figure 21. Biological Hemostatic Material Consumed in Other
Figure 22. Global Biological Hemostatic Material Market: Other (2021-2026) & (K Units)
Figure 23. Global Biological Hemostatic Material Sale Market Share by Application (2025)
Figure 24. Global Biological Hemostatic Material Revenue Market Share by Application in 2026
Figure 25. Biological Hemostatic Material Sales by Company in 2026 (K Units)
Figure 26. Global Biological Hemostatic Material Sales Market Share by Company in 2026
Figure 27. Biological Hemostatic Material Revenue by Company in 2026 ($ millions)
Figure 28. Global Biological Hemostatic Material Revenue Market Share by Company in 2026
Figure 29. Global Biological Hemostatic Material Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Biological Hemostatic Material Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Biological Hemostatic Material Sales 2021-2026 (K Units)
Figure 32. Americas Biological Hemostatic Material Revenue 2021-2026 ($ millions)
Figure 33. APAC Biological Hemostatic Material Sales 2021-2026 (K Units)
Figure 34. APAC Biological Hemostatic Material Revenue 2021-2026 ($ millions)
Figure 35. Europe Biological Hemostatic Material Sales 2021-2026 (K Units)
Figure 36. Europe Biological Hemostatic Material Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Biological Hemostatic Material Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Biological Hemostatic Material Revenue 2021-2026 ($ millions)
Figure 39. Americas Biological Hemostatic Material Sales Market Share by Country in 2026
Figure 40. Americas Biological Hemostatic Material Revenue Market Share by Country (2021-2026)
Figure 41. Americas Biological Hemostatic Material Sales Market Share by Type (2021-2026)
Figure 42. Americas Biological Hemostatic Material Sales Market Share by Application (2021-2026)
Figure 43. United States Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Biological Hemostatic Material Sales Market Share by Region in 2026
Figure 48. APAC Biological Hemostatic Material Revenue Market Share by Region (2021-2026)
Figure 49. APAC Biological Hemostatic Material Sales Market Share by Type (2021-2026)
Figure 50. APAC Biological Hemostatic Material Sales Market Share by Application (2021-2026)
Figure 51. China Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 55. India Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Biological Hemostatic Material Sales Market Share by Country in 2026
Figure 59. Europe Biological Hemostatic Material Revenue Market Share by Country (2021-2026)
Figure 60. Europe Biological Hemostatic Material Sales Market Share by Type (2021-2026)
Figure 61. Europe Biological Hemostatic Material Sales Market Share by Application (2021-2026)
Figure 62. Germany Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 63. France Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Biological Hemostatic Material Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Biological Hemostatic Material Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Biological Hemostatic Material Sales Market Share by Application (2021-2026)
Figure 70. Egypt Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Biological Hemostatic Material Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Biological Hemostatic Material in 2026
Figure 76. Manufacturing Process Analysis of Biological Hemostatic Material
Figure 77. Industry Chain Structure of Biological Hemostatic Material
Figure 78. Channels of Distribution
Figure 79. Global Biological Hemostatic Material Sales Market Forecast by Region (2027-2032)
Figure 80. Global Biological Hemostatic Material Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Biological Hemostatic Material Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Biological Hemostatic Material Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Biological Hemostatic Material Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Biological Hemostatic Material Revenue Market Share Forecast by Application (2027-2032)